Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China
- PMID: 37364025
- PMCID: PMC10436143
- DOI: 10.1093/jamia/ocad116
Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China
Abstract
Background: Long-lasting nonpharmaceutical interventions (NPIs) suppressed the infection of COVID-19 but came at a substantial economic cost and the elevated risk of the outbreak of respiratory infectious diseases (RIDs) following the pandemic. Policymakers need data-driven evidence to guide the relaxation with adaptive NPIs that consider the risk of both COVID-19 and other RIDs outbreaks, as well as the available healthcare resources.
Methods: Combining the COVID-19 data of the sixth wave in Hong Kong between May 31, 2022 and August 28, 2022, 6-year epidemic data of other RIDs (2014-2019), and the healthcare resources data, we constructed compartment models to predict the epidemic curves of RIDs after the COVID-19-targeted NPIs. A deep reinforcement learning (DRL) model was developed to learn the optimal adaptive NPIs strategies to mitigate the outbreak of RIDs after COVID-19-targeted NPIs are lifted with minimal health and economic cost. The performance was validated by simulations of 1000 days starting August 29, 2022. We also extended the model to Beijing context.
Findings: Without any NPIs, Hong Kong experienced a major COVID-19 resurgence far exceeding the hospital bed capacity. Simulation results showed that the proposed DRL-based adaptive NPIs successfully suppressed the outbreak of COVID-19 and other RIDs to lower than capacity. DRL carefully controlled the epidemic curve to be close to the full capacity so that herd immunity can be reached in a relatively short period with minimal cost. DRL derived more stringent adaptive NPIs in Beijing.
Interpretation: DRL is a feasible method to identify the optimal adaptive NPIs that lead to minimal health and economic cost by facilitating gradual herd immunity of COVID-19 and mitigating the other RIDs outbreaks without overwhelming the hospitals. The insights can be extended to other countries/regions.
Keywords: Covid-19; artificial intelligence; infectious diseases; machine learning; mathematical modelling; reinforcement learning.
© The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
All authors declare no competing interests.
Figures








Similar articles
-
Future trajectory of respiratory infections following the COVID-19 pandemic in Hong Kong.Chaos. 2023 Jan;33(1):013124. doi: 10.1063/5.0123870. Chaos. 2023. PMID: 36725657
-
Sustainable targeted interventions to mitigate the COVID-19 pandemic: A big data-driven modeling study in Hong Kong.Chaos. 2021 Oct;31(10):101104. doi: 10.1063/5.0066086. Chaos. 2021. PMID: 34717342
-
Assessing the impact of COVID-19 interventions on influenza-like illness in Beijing and Hong Kong: an observational and modeling study.Infect Dis Poverty. 2023 Feb 16;12(1):11. doi: 10.1186/s40249-023-01061-8. Infect Dis Poverty. 2023. PMID: 36797765 Free PMC article.
-
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5. Expert Rev Vaccines. 2022. PMID: 36039786 Review.
-
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.Viruses. 2024 Mar 11;16(3):429. doi: 10.3390/v16030429. Viruses. 2024. PMID: 38543794 Free PMC article.
Cited by
-
Reinforcement learning for healthcare operations management: methodological framework, recent developments, and future research directions.Health Care Manag Sci. 2025 Jun;28(2):298-333. doi: 10.1007/s10729-025-09699-6. Epub 2025 Apr 9. Health Care Manag Sci. 2025. PMID: 40202690 Free PMC article. Review.
-
The Implications of Artificial Intelligence on Infection Prevention and Control: Current Progress and Future Perspectives.China CDC Wkly. 2024 Aug 30;6(35):901-904. doi: 10.46234/ccdcw2024.192. China CDC Wkly. 2024. PMID: 39233995 Free PMC article. No abstract available.
-
Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges.Nat Commun. 2025 Jan 10;16(1):581. doi: 10.1038/s41467-024-55461-x. Nat Commun. 2025. PMID: 39794317 Free PMC article.
-
AI-driven techniques for detection and mitigation of SARS-CoV-2 spread: a review, taxonomy, and trends.Clin Exp Med. 2025 Jun 14;25(1):204. doi: 10.1007/s10238-025-01753-5. Clin Exp Med. 2025. PMID: 40515956 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical